Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. U.S. Venture Partners (USVP), led the round. Participation included new […]
SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, today announced that it has conducted the first implantations of its novel BowTie SI Fusion System. The surgeries began on October 14th and were conducted by Dr. Peter Whang, Associate Professor of Orthopaedics […]
Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee (BTK) RECOIL study. This Core Lab-Adjudicated Recoil analysis, the first of its kind, evaluated vessel recoil in lesions treated with Serranator® verses Plain Old Balloon Angioplasty (POBA). The study results demonstrated that lesions treated using […]
CampusESP, the leading provider of technology solutions that help colleges and universities engage parents and families, announced today that it signed its 300th customer, the University of Kentucky. Founded in 2016, CampusESP has built a reputation as the go-to leader in parent and family engagement solutions, leading with the message that a strong family […]
WizeHive, a leading provider of Grants Management software, today announced a merger with Bright Funds, a leading provider of workplace giving and volunteerism solutions. By bringing together two best-of-breed software providers that power corporate philanthropic missions, WizeHive and Bright Funds will deliver a single SaaS solution that meets the full range of corporate giving needs […]
Mitochon Pharmaceuticals today announced that they, in partnership with the University of Kentucky (UK) and Children’s Hospital of Philadelphia (CHOP), were awarded a $3.2M National Institutes of Health grant to study Mitochon’s mitochondrial targeted drug therapies for treating Traumatic Brain Injury (TBI). This important award, along with the Company’s open IND, will help pave the […]
WAYNE, Pa.–(BUSINESS WIRE)– Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions. The Serranator device is the first and only angioplasty balloon FDA Cleared and CE Marked that embeds serration technology into a semi-compliant […]
ABBYY, a global leader in Content IQ technologies and solutions, today announced it has signed an agreement to acquire Philadelphia, Pennsylvania-based TimelinePI. TimelinePI provides a comprehensive process intelligence platform designed to empower users to understand, monitor and optimize any business process. The global process analytics market size is expected to grow to USD 1,421.7 million by […]
SFA Therapeutics today announced approval of the second key U.S. patent derived from its research & development program, which utilizes microbiome-derived metabolite small molecules as drugs to modulate the body’s anti-inflammatory and immune systems. As a result of this new patent, targeting Ffar2 (GPR43) and Ffar3 (GPR441) and down-regulation of NF-ĸB, the therapeutic applications of […]
Teleflex Incorporated (NYSE: TFX) today announced that it has acquired Essential Medical, Inc. Based in Exton, PA, Essential Medical is a privately-held medical device company that has developed and commercialized the CE Marked MANTA™ Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing devices or sheaths ranging in size from […]